|Articles|September 3, 2019
N-1 Bioreactor Perfusion Capability
Author(s)Samsung Biologics
Related Content
Trending on Pharmaceutical Technology
1
What the McKesson-Precision Medicine Deal Signals for Trial Sponsors
2
GSK's Jemperli Rectal Cancer Filing Signals Biologics Capacity Shift
3
From Detection to Prediction: Modern Analytical Approaches for Nitrosamine Risk
4
3D Printing Revolutionizing Tissue Engineering and Regenerative Medicine in Europe
5